$ENZC Enzolytics, Inc. Highlights Plans for Promotion of IPF Immune(TM), Its Patented Nutraceutical Supplement accesswire.com/741133/Enzolyt…
- $ENZC Enzolytics, Inc. Announces Production and Sale inNorth America of “Enzolytics IPF Immune(TM)”,A New Dietary ... accesswire.com/680815/Enzolyt…
- $ENZC Enzolytics Announces Preliminary Results of GLP Toxicology Study for its anti-HIV Therapeutic ITV-1 and Production ... accesswire.com/738516/Enzolyt…
- $ENZC Enzolytics Announces the International Patent Office Search Report finding Novelty and Inventiveness in the ... accesswire.com/710061/Enzolyt…
- $ENZC Enzolytics, Inc. Announces the Completion of the 2020 and 2021 Audited Financials accesswire.com/732304/Enzolyt…
- $ENZC Enzolytics, Inc. Announces U.S. Distribution of IPF Immune(TM) and Progress in each of its Therapeutic Platforms ... accesswire.com/731575/Enzolyt…
- $ENZC Enzolytics IPF Immune(TM) Introduced to Large and Small Retail Buyers at Recent ECRM "Weight Management, Nutrition, ... accesswire.com/696842/Enzolyt…
- $ENZC Enzolytics, Inc. Highlights the Introduction of IPF Immune(TM) as CRN Data Shows Record-Breaking Number of ... accesswire.com/694269/Enzolyt…
- $ENZC Enzolytics, Inc. Announces Expansion of Production of Its Monoclonal Antibody Therapeutics and Marketing of ... accesswire.com/726257/Enzolyt…
- $ENZC Enzolytics Reports Successful Completion of an MTD Tolerability Study of Its ITV-1 anti-HIV Therapeutic Leading ... accesswire.com/718850/Enzolyt…
- $ENZC Enzolytics Reports Its Engagement of Scendea USA, Inc., a Leading International Product Development and Regulatory ... accesswire.com/679980/Enzolyt…
- $ENZC Enzolytics, Inc. Announces Program for Creation of Multiple Monoclonal Antibodies for Veterinary Application ... accesswire.com/671562/Enzolyt…
- $ENZC Virogentics Inc. Announces Pilot Clinical Trial of ITV-1 at National Center for Endocrinology in Bulgaria and ... accesswire.com/753400/Virogen…
